for the Cornea Donor Study Investigator Group Purpose: To assess corneal thickness (CT) and correlation with graft outcome after penetrating keratoplasty in the Cornea Donor Study.
T he Cornea Donor Study (CDS) was designed to determine whether graft survival over a 5-year period after penetrating keratoplasty (PK) is similar using older donor tissue (age 66-75 years) versus younger tissue (age 10-65 years). Donor age was found to have no effect on graft survival. 1 The CDS was designed to track other PK-related parameters. This randomized, prospective, large multicenter trial with tight adherence to a 5-year follow-up (since expanded to 10 years) has generated data that advance our knowledge of graft longevity, endothelial cell loss, graft rejection, and donor and recipient risk factors for graft failure. [1] [2] [3] [4] [5] [6] In this report based on the 5-year data, we analyze the course of postkeratoplasty corneal thickness (CT) and its correlation with outcomes.
MATERIALS AND METHODS

Study Protocol
Previous publications provide details on the CDS and the Specular Microscopy Ancillary Study protocols 1, 2 ; pertinent aspects are described here. Eligibility criteria for study recipients included age between 40 and 80 years and corneal disease associated with moderate risk of failure, principally Fuchs dystrophy and pseudophakic or aphakic corneal edema. Corneas eligible for transplantation were from donors aged 10 to 75 years with a preoperative, baseline eye bank-determined endothelial cell density (ECD) of between 2300 and 3300 cells per square millimeter.
Preoperative care, surgical technique, and postoperative care (including prescription of medications) were provided according to each clinical investigator's customary routine. Annual follow-up continued through 5 years after surgery unless a regraft occurred before that time. In addition to a regraft, a graft was considered to have failed if there was loss of central graft clarity sufficient to compromise vision for a minimum of 3 consecutive months.
CT measurements were optional at postkeratoplasty follow-up visits at month 6, year 1, and annually through year 5. Central CT was measured using an ultrasonic pachymeter by the investigator's usual routine. Measurements of central CT were recorded to the nearest micrometer. If a CT measurement was not possible because the cornea was too thick, this was noted on the data collection form.
A subset of the CDS participants also consented to participation in the Specular Microscopy Ancillary Study. Preoperative specular microscopic images of the central donor corneal endothelium were provided by the eye banks. Postoperative specular microscopic images of the central corneal endothelium of the graft were obtained at the 6-month and annual follow-up visits. The preoperative donor images and postoperative recipient images were evaluated for quality and ECD by a central reading center, the Cornea Image Analysis Reading Center (formerly the Specular Microscopy Reading Center) at the Case Western Reserve University and University Hospitals Eye Institute, using a previously described variable frame analysis method. 7 To be included in this analysis cohort, a participant needed to have had a condition associated with endothelial dysfunction as the indication for the initial PK, and if graft failure occurred, the failure needed to be as a result of endothelial dysfunction with or without graft rejection. With these restrictions, the analysis cohort included 887 of the 1090 CDS participants, 65 of whom experienced graft failure (28 associated with graft rejection and 37 without rejection) and 822 who did not experience graft failure by the conclusion of the 5-year follow-up. Among participants who experienced graft failure, only CT measurements obtained before graft failure were included, and the analysis was therefore conditional on graft survival.
Because CT measurements were optional, thickness data were not available for all participants. Of the 4663 completed visits from 887 participants, a CT measurement was available for 3376 visits (72%). Eighty-seven percent of the 887 participants had $2 CT measurements and 73% had $3 CT measurements. The CT availability varied by study site ranging from 0% to 100%. A sensitivity analysis was performed to assess whether the missing data might have impacted these results. When restricting this data set to 20 of the 78 sites (26%), where $85% of visits included a CT measurement (a total of 1620 CT measurements from 1745 visits), results were similar to those from the entire cohort (data not shown).
Statistical Analyses
The CT measurements obtained during the study followup were verified to have an approximately normal distribution by assessment of histograms, q-q plots, and regression residuals. Means 6 SDs were therefore used to characterize the distribution of the CT values. The relationships between baseline (recipient, donor, and operative) factors and CT were explored in analyses that paralleled the previously published analyses of ECD. 9 Longitudinal repeated measures models were used to evaluate CT changes throughout follow-up. The final multivariate model was generated through stepwise selection of covariates at a significance level of 0.01. The large number of statistical comparisons increases the likelihood of a false positive, and no attempt was made to control the overall type I error in these exploratory analyses.
Five-year rates of graft failure were calculated using cumulative incidence. The cutoff points for CT categories were specified before data analysis. The proportional hazards model was used to assess the association of graft failure and CT at 6 months and 1 year postoperatively. Significant departure from linearity was detected by adding a quadratic term to the model. CT was therefore analyzed as a discrete variable in all proportional hazards models. The models, adjusted with the ECD, were limited to participants with both CT and ECD values at the corresponding follow-up time. Models were also fit with the most recent CT value as a timedependent variable. For the models with CT as a timedependent covariate, similar results were obtained when missing values were imputed using the Rubin method of multiple imputation (data not shown). Proportional hazards assumptions were verified using time-dependent variables with logarithmic transformation of time. No significant deviation from the proportional hazards assumption was detected for these models.
The relationship between the CT and ECD was assessed with a longitudinal repeated measures model and with Spearman correlation estimates at each follow-up time. All reported P values are 2-sided. Statistical analyses were conducted using SAS version 9.2 statistical software (SAS Institute Inc, Cary, NC).
RESULTS
The mean (6SD) age of the 887 participants included in the analysis was 70 6 8 years; 562 (63%) were women and 830 (94%) were white non-Hispanic individuals. At the beginning of the study, these participants underwent PK for the following indications: Fuchs dystrophy (65%), pseudophakic or aphakic corneal edema (31%), and a variety of other diagnoses (4%). Other baseline recipient, donor, and operative characteristics were comparable with those in previous CDS analyses cohorts.
CT Measurements Over Time
The mean central CT among participants without graft failure increased steadily during the study follow-up ( Fig. 1 ). At 6 months, the mean (6SD) CT was 535 6 45 mm and increased to 580 6 59 mm at 5 years, which represented a relative change of 9% 6 11%. Between 6 months and 5 years, CT decreased for 18% of the 378 participants without failure. At 6 months, the median ECD (interquartile range) was 2519 cells per square millimeter (2152-2912 cells/mm 2 ) and decreased to 792 cells per square millimeter (580-1296 cells/mm 2 ) at 5 years, which represented a median cell loss of 65% (48%-74%). The increase in CT was modestly associated with the loss of endothelial cells during the study follow-up (P , 0.001; Fig. 2 ). At 6 months, the Spearman correlation between CT and ECD values was 20.09 [95% confidence interval (CI): 20.21 to 0.03, P = 0.15, n = 261), and was 20.30 (95% CI: 20.40 to 20.20, P , 0.001, n = 304) at 5 years. The correlation between the change in CT and the change in ECD at 5 years (Spearman correlation coefficient = 20.29, 95% CI: 20.43 to 20.14, P , 0.001, n = 146) was similar to the correlation between the CT and ECD values at 5 years.
CT and Baseline Factors
In longitudinal multivariate analysis, higher CT measurements during follow-up were associated with a baseline diagnosis of pseudophakic or aphakic corneal edema (P , 0.001), intraocular pressure (IOP) .25 mm Hg during the first postoperative month (P = 0.003), white (non-Hispanic) donor race (P = 0.002; Table 1 ), and respiratory causes of donor death, which included respiratory failure and other respiratory diseases (P , 0.001; Table 1 ). Nonwhite (including Hispanic) recipient race was significantly associated with CT in univariate analysis, but it did not reach the significance level of ,0.01 in the multivariate analysis because of confounding with baseline diagnosis. The number of nonwhite or Hispanic donors and recipients was too small to evaluate any interaction between recipient and donor race. Other baseline factors associated with CT that demonstrated a P value of ,0.01 in univariate analyses, but were no longer significant at this level in multivariate analyses, included recipient sex, recipient glaucoma history, preoperative lens status, donor tissue size, vitrectomy, and donor history of diabetes. The principal confounding factor accounting for the differences between the univariate and multivariate analyses was corneal diagnosis for the recipient and operative factors and cause of death for the donor diabetes history. Donor age was not significantly associated with CT values in univariate (P = 0.35) or multivariate analyses (P = 0.31). No other recipient (age, history of diabetes, smoking status), operative (recipient bed CT and Graft Failure Figure 3 illustrates that CT was predictive of graft failure with larger CT values among the 65 cases whose graft subsequently failed compared with 822 nonfailure cases. Among those whose graft did not fail within the first year after PK, the 5-year cumulative incidence (695% CI) of graft failure was 5% 6 5% in the participants with a 1-year CT #500 mm, 5% 6 3% in those with a 1-year CT 501 to 550 mm, 7% 6 4% in those with a 1-year CT 551 to 600 mm, and 20% 6 11% in those with a 1-year CT .600 mm (Fig. 4) . In univariate analysis, the 1-year CT was associated with subsequent graft failure (P = 0.002; Table 2 ). In multivariate analysis, a CT .600 mm was still associated with graft failure after adjusting for ECD ( Table 2 ). In an analysis of CT as a time-dependent variable, the most recent CT value was predictive of graft failure ( Table 2) . A trend toward more subsequent graft failures with higher change in CT from 6 months to 1 year was demonstrated when the change in CT was added to the model with the 1-year CT; however, this association was not statistically significant (data not shown).
DISCUSSION
Increased or progressive CT measurements may offer an early warning of rejection, endothelial cell loss, inflammation, or other causes of endothelial cell dysfunction. However, CT measurements alone are not a reliable indicator of corneal health or decompensation. There is a large range of CT found in normal eyes. In a metaanalysis of healthy unoperated eyes, mean CT was 534 mm (472-596 6 2 SD). 10 Mean CT was 544 mm when the analysis was narrowed to studies based on ultrasound technology. Corneal decompensation and associated vision loss usually occur once CT exceeds a threshold beyond 600 to 650 mm. 11, 12 A decrease in CT within the first 6 months after PK has been attributed to recovery of the donor endothelium after the initial insult of surgery. [13] [14] [15] Borderie et al 16 documented a decrease in CT from an average of 655 mm at 1 week to 558 mm at 1 month, and 533 mm at 6 months, before increases beginning at 1 year (538 mm). Lass et al 14 reported a decrease in average graft thickness after PK from 595 mm at 1 week to 520 mm at 3 months. CT measurements were not obtained during the first 6 postoperative months for the CDS.
In the CDS, mean CT increased steadily from 6 months postoperatively throughout the remaining 5-year follow-up period. Previous studies have shown similar results ( Table 3 ). In a retrospective study of 856 consecutive PK patients, Borderie et al 16 obtained ultrasonic CT measurements with mean CT of 533 mm at 6 months, 538 mm at 1 year, 558 mm at 2 years, 561 mm at 3 years, and 568 mm at 4 and 5 years. Patel et al 17 followed up 500 consecutive PK eyes with CT measured by contact specular microscopy, with mean CT of 540 mm at 1 year, 560 mm at 3 years, 570 mm at 5 years, 580 mm at 10 years, and 590 mm at 15 years. In each of these series, CT was measured in clear grafts.
Given the role of corneal endothelium in maintaining corneal hydration, and the 70% endothelial cell loss over 5 years in successful grafts, 2 the finding of increasing CT over time after PK is expected. Kopplin et al 18 have shown that in eyes with Fuchs dystrophy without slit-lamp evidence of corneal edema, increasing CT is associated with increasing guttae.
In the CDS, we observed an almost linear relationship between increasing CT and decreasing ECD from 6 months postoperatively to 5 years after PK. The correlation, however, was relatively small, accounting for ,10% of the variance in thickness. Both CT and ECD were independently predictive of graft failure. Borderie et al 16 reported a similar relationship between CT and graft failure, documenting that at time points up to 5 years, subsequent graft survival was lower in patients with increased CT compared with those with normal CT. 16 In PK eyes at high risk for immunologic graft failure followed up for 3 years in the Collaborative Corneal Transplantation Studies, increased CT at 1, 3, and 6 months postoperatively and change in CT between visits were predictive of graft failure. 19 In the CDS, PK recipients with a preoperative diagnosis of pseudophakic or aphakic corneal edema were more likely to have increased CT during the 5-year follow-up period than those with Fuchs dystrophy (P , 0.001). Previous CDS univariate and multivariate analyses showed a 4-fold increased risk for graft failure in recipients with aphakic or pseudophakic edema compared with those with Fuchs dystrophy (27% vs. 7%). 4 Factors contributing to an increased rate of graft failure in aphakic or pseudophakic eyes are not well defined but are likely related to both endothelial cell dysfunction and associated corneal thickening.
Postoperative CT was higher in eyes with an elevated IOP within the first postoperative month. Although the association between increased IOP and increased CT has been well documented, 18, 20 the causal relationship appears to be complex, with mechanisms not well understood. Patients with ocular hypertension are more likely to have increased CT, 21 in contrast to those with normal tension glaucoma or primary open-angle glaucoma who are more likely to have average or lower-than-average CT. 22 It is unclear which of our patients with elevated IOP readings within the first postoperative month may have had ocular hypertension, primary open-angle glaucoma, or angle closure, or were steroid responders. Measuring artifact from applanation tonometry, which causes overestimation of IOP in thicker corneas, may in part account for our results. 10, 23 A relationship between respiratory cause of donor death and increased postoperative CT has not been previously observed. A possible mechanism is reduced endothelial cell function after prolonged hypoxia. Donor death from respiratory causes was not a risk factor for graft failure in the CDS. 3 It is possible that this finding is a false-positive result from type I error because of inclusion of a large number of variables in our analyses.
White (non-Hispanic) donor race was associated with increased recipient CT compared with nonwhite or Hispanic donor race at 6 months to 5 years postoperatively. This finding may be a result of racial differences in CT. African Americans have lower mean CT measurements than whites, with Hispanics similar to whites. 21, 22, 24, 25 Although our study had the benefit of data acquired in a prospective, randomized, large clinical trial with excellent patient follow-up, there are several limitations. Our study results were limited by the fact that CT measurements during follow-up were obtained at the discretion of the surgeon. About 87% of the participants had $2 measurements, 73% had $3 measurements, and 40% had $5 measurements.
The CDS cohort was restricted to eyes at low to mid risk for graft failure after PK for endothelial disease. Eyes with corneal decompensation due to other causes, especially those at high risk for graft failure due to stromal neovascularization or past graft failure, might yield different results. Most of the eyes on which we performed PK would today likely undergo an endothelial replacement procedure such as Descemet stripping endothelial keratoplasty or Descemet membrane endothelial keratoplasty, with possibly different CT findings and correlations.
Our major findings include establishing normative values for CT after PK in eyes at low to mid risk for graft failure. We have established that, at least during the first 5 years after PK, CT can serve as a predictor of graft survival. Considering the advantages of obtaining CT versus ECD measurements in terms of ease, expense, and availability, it is tempting but incorrect to consider CT as a proxy for ECD. Each serves as an independent predictor of graft failure and †The Cox model includes 320 participants with both CT and ECD values at 1 year. There were no events among the 54 subjects with 1-year CT #500 mm and the categories #500 mm and 501 to 550 mm were combined into one for this model.
‡The Cox model includes the entire analysis cohort (subjects with $1 follow-up CT measurements). measures different parameters of corneal health. We hope that future research will allow better utilization of CT as a way of assessing prophylaxis or treatment options for graft failure and corneal disease. For example, if low-grade rejection or inflammation exists as a cause of graft failure, might longterm or more aggressive steroid treatment be evaluated with CT and/or ECD measurements?
